About 1 in 4 overall and two thirds of those taking doses of 50 µg/d or lower were able to come off the treatment while maintaining adequate thyroid function for 1 year.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/levothyroxine-discontinuation-safe-many-older-adults-2026a1000aj5
via IFTTT

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/chemotherapy-boosts-survival-older-patients-tnbc-2026a1000ahw
via IFTTT

The rate at which individuals with darker skin tones take steps to protect themselves from the sun has doubled in 20 years, but there is a great distance to go.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/over-20-years-sunscreen-use-doubled-among-black-individuals-2026a1000ahb
via IFTTT

Patients often withhold key health information during consultations, which may contribute to delayed diagnosis, unnecessary testing, and suboptimal clinical decisions.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/patient-nondisclosure-may-compromise-diagnosis-and-care-2026a1000aho
via IFTTT

Emerging research and anecdotal reports suggest that the weight-loss drugs may cause vulvar and urogenital changes.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/nuanced-sexual-and-pelvic-floor-effects-glp-1s-women-2026a1000ah4
via IFTTT

State bans on conversion therapy remain enforceable after the US Supreme Court’s ruling, but experts warn the decision may invite new legal challenges.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/scotus-conversion-therapy-ruling-what-you-should-know-2026a1000agn
via IFTTT

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect patient care.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/mdangle-aan-2026-multiple-sclerosis-rrms-overview-and-poll-2026a10007p6
via IFTTT

In the latest Skills Lab, Dr Bishal Gyawali breaks down effect size in oncology, revealing how overpowered trials can turn trivial gains into ‘significant’ results.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/beyond-p-values-defining-true-clinical-effect-size-2026a10009ol
via IFTTT

To confront its GP shortage, Australia is expanding rural training, funding, and new medical school models to rebuild its primary care workforce.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/rethinking-gp-training-meet-australias-rising-demand-2026a10009tj
via IFTTT

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/early-psa-detection-biomarkers-and-genetics-2026a10009y5
via IFTTT